Corbus Pharmaceuticals Holdings, Inc.·4

Mar 4, 6:44 PM ET

Millian Craig Stuart 4

4 · Corbus Pharmaceuticals Holdings, Inc. · Filed Mar 4, 2019

Insider Transaction Report

Form 4
Period: 2019-02-28
Millian Craig Stuart
Chief Commercial Officer
Transactions
  • Award

    Stock Option(right to buy)

    2019-02-28+180,000180,000 total
    Exercise: $6.94Exp: 2029-02-28Common Stock (180,000 underlying)
Footnotes (1)
  • [F1]The option award was made in accordance with the terms of the issuer's 2014 Equity Compensation Plan. 25% of the option vests on February 28, 2020, with the remaining 75% of the option vesting in equal monthly installments over a period of 36 months commencing on March 28, 2020.

Documents

1 file
  • 4
    doc4.xmlPrimary

    FORM 4 SUBMISSION